 |
The Journal of Neuroscience, March 12, 2008, 28(11):2783-2792; doi:10.1523/JNEUROSCI.0106-08.2008
Previous Article | Next Article 
Neurobiology of Disease
N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking
Adam L. Orr,1
Shihua Li,1
Chuan-En Wang,1
He Li,1,2
Jianjun Wang,1
Juan Rong,1
Xingshun Xu,1
Pier Giorgio Mastroberardino,3
J. Timothy Greenamyre,3 and
Xiao-Jiang Li1
1Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, 2Division of Histology and Embryology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China, and 3Pittsburgh Institute for Neurodegenerative Diseases and the Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260
Correspondence should be addressed to Dr. Xiao-Jiang Li, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322. Email: xiaoli{at}genetics.emory.edu
Huntington's disease (HD) is caused by polyglutamine (polyQ) expansion in huntingtin (htt), a large (350 kDa) protein that localizes predominantly to the cytoplasm. Proteolytic cleavage of mutant htt yields polyQ-containing N-terminal fragments that are prone to misfolding and aggregation. Disease progression in HD transgenic models correlates with age-related accumulation of soluble and aggregated forms of N-terminal mutant htt fragments, suggesting that multiple forms of mutant htt are involved in the selective neurodegeneration in HD. Although mitochondrial dysfunction is implicated in the pathogenesis of HD, it remains unclear which forms of cytoplasmic mutant htt associate with mitochondria to affect their function. Here we demonstrate that specific N-terminal mutant htt fragments associate with mitochondria in Hdh(CAG)150 knock-in mouse brain and that this association increases with age. The interaction between soluble N-terminal mutant htt and mitochondria interferes with the in vitro association of microtubule-based transport proteins with mitochondria. Mutant htt reduces the distribution and transport rate of mitochondria in the processes of cultured neuronal cells. Reduced ATP level was also found in the synaptosomal fraction isolated from Hdh(CAG)150 knock-in mouse brain. These findings suggest that specific N-terminal mutant htt fragments, before the formation of aggregates, can impair mitochondrial function directly and that this interaction may be a novel target for therapeutic strategies in HD.
Key words: polyglutamine; mitochondria; trafficking; neurodegeneration; Huntington's disease; proteolysis
Received Aug. 15, 2007;
revised Feb. 4, 2008;
accepted Feb. 4, 2008.
Correspondence should be addressed to Dr. Xiao-Jiang Li, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322. Email: xiaoli{at}genetics.emory.edu
This article has been cited by other articles:

|
 |

|
 |
 
H. Chen and D. C. Chan
Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases
Hum. Mol. Genet.,
October 15, 2009;
18(R2):
R169 - R176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Chaturvedi, P. Adhihetty, S. Shukla, T. Hennessy, N. Calingasan, L. Yang, A. Starkov, M. Kiaei, M. Cannella, J. Sassone, et al.
Impaired PGC-1{alpha} function in muscle in Huntington's disease
Hum. Mol. Genet.,
August 15, 2009;
18(16):
3048 - 3065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, P. J. Lim, M. Karbowski, and M. J. Monteiro
Effects of overexpression of Huntingtin proteins on mitochondrial integrity
Hum. Mol. Genet.,
February 15, 2009;
18(4):
737 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-S. Her and L. S. B. Goldstein
Enhanced Sensitivity of Striatal Neurons to Axonal Transport Defects Induced by Mutant Huntingtin
J. Neurosci.,
December 10, 2008;
28(50):
13662 - 13672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-E. Wang, S. Tydlacka, A. L. Orr, S.-H. Yang, R. K. Graham, M. R. Hayden, S. Li, A. W.S. Chan, and X.-J. Li
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease
Hum. Mol. Genet.,
September 1, 2008;
17(17):
2738 - 2751.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|